MTOR and familial pancreatic carcinoma: Previous studies have described that orexin-A treatment can regulate theAkt/mTOR pathway in malignant tumors or tissues (24, 28), encouraging us to clarify the mechanism of orexin-A-regulated cell proliferation in pancreatic cancer cells.